Knowledge Hub

Global Gastrointestinal Therapeutics Market To Grow At A CAGR Of 6.5% During The Period 2016-2020

Press Release   •   Oct 13, 2016 07:21 EDT

MarketResearchReports.biz has recently announced the addition of a market study “ Global Gastrointestinal Therapeutics Market 2016-2020”, is acomparative analysis of the global market.

About Gastrointestinal Disorders

Gastrointestinal disorders include both functional and motility disorders affecting the gastrointestinal tract. Functional disorders involve an abnormality in the working of the gastrointestinal tract. They are the most common type of disorders and present with disturbances in motility, visceral hypersensitivity, changes in the mucosal and immune function, variations in central nervous system processing, and altered gut microbiota. Motility disorders are characterized by changes in the movement of the gastrointestinal tract and the transfer of its contents. Some of the most common gastrointestinal functional and motility disorders include IBS, GERD, Crohns disease, ulcerative colitis, and peptic ulcers.

Technavios analysts forecast the global gastrointestinal therapeutics market to grow at a CAGR of 6.5% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global gastrointestinal therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of various gastrointestinal disorders including IBD, and irritable bowel syndrome (IBS).

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Technavio's report, Global Gastrointestinal Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/834792

Key vendors

AbbVie

Johnson & Johnson

Takeda

Allergan

UCB

Other prominent vendors

4SC

Ajinomoto Pharmaceuticals

Alfa Wassermann

Alizyme

Amgen

Anterogen

Ardelyx

Arena Pharmaceuticals

Astellas

AstraZeneca

Astellas Pharma

Avaxia Biologics

Biogen Idec

BioLineRx

Celgene

ChemoCentryx

Cosmo Pharmaceuticals

Drais Pharmaceuticals

Eisai

Eli Lilly

Enlivex Therapeutics

F. Hoffmann-La Roche

Ferring Pharmaceuticals

FF Pharma

Galapagos

Gilead Sciences

GlaxoSmithKline

Hutchison Medi Pharma

Immune Pharmaceuticals

InDex Pharmaceuticals

Ironwood Pharmaceuticals

Kaken Pharmaceutical

Kang Stem Biotech

Kissei Pharmaceutical

Kyowa Hakko Kirin

Lexicon Pharmaceuticals

Lipid Therapeutics

Meda

Merck

Mesoblast

Mitsubishi Tanabe

Mochida Pharmaceutical

Morphotek

Neovacs

Nestle

Norgine

Novartis

Ono Pharmaceutical

Pfizer

Procter & Gamble

Qu Biologics

Receptos

RedHill Biopharma

Salix Pharmaceuticals

Shield Therapeutics

Sterna Biologicals

Synergy Pharmaceuticals

Synthetic Biologics

TiGenix

Tillotts Pharma

TopiVert

TSD Japan

Zeria Pharmaceutical

Market driver

Tentative approval of late stage molecules

For a full, detailed list, view our report

Market challenge

Discontinuation of drugs under development and from the market

For a full, detailed list, view our report

Market trend

Emergence of biosimilars

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.